DoMore Diagnostics
PrivateLast Round
Grant
Feb 25, 2025
Total Funding Raised
$15.67M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DoMore Diagnostics is a healthcare company that develops AI-based diagnostic tools to guide individualized cancer treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Precision Medicine, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DoMore Diagnostics Comparables
Compare DoMore Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stratipath | 81% | |
| Qritive | 77% | |
| Histofy | 77% |
DoMore Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 25, 2025 | ||||
| Grant | Feb 28, 2024 | ||||
| Grant | Dec 18, 2023 | ||||
| Seed | Jun 28, 2021 |
Key People
Founding team and executive leadership
DoMore Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Norselab | Seed |
| European Innovation Council (EIC) Accelerator | Grant |
| The Research Council of Norway | Grant |
| EIC Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 146% MoM.
- Nov 15, 2025
Grew 25% QoQ, from 12 to 15 employees.
DoMore Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DoMore Diagnostics's valuation, stock price, and market status.
Is DoMore Diagnostics a public or private company?
DoMore Diagnostics is a private company.
What is the current stock price of DoMore Diagnostics?
DoMore Diagnostics is a private company, so its shares have no public market price. Caplight tracks DoMore Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DoMore Diagnostics worth (valuation)?
Valuation information for DoMore Diagnostics is not publicly available.
Can I buy DoMore Diagnostics stock?
DoMore Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DoMore Diagnostics's last funding round?
DoMore Diagnostics's most recent funding round was Grant on February 25, 2025.
Who are the main investors in DoMore Diagnostics?
Key investors in DoMore Diagnostics include European Innovation Council (EIC) Accelerator.
Will DoMore Diagnostics IPO soon?
No public IPO plans have been announced for DoMore Diagnostics.
How can I track DoMore Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in DoMore Diagnostics's shares on secondary markets.